A thought leadership article by Peter Schueler and Haichen Yang on the key considerations for disease modifying parkinson's disease trials. This article is featured in Pharmaceutical Market Europe (PME).
CNS, Pain and Ageing related disorders insights
ICON's experienced neuroscience and drug development teams regularly share their insights in industry publications and through ICON produced content in the form of blogs and whitepapers. Read more content from our experts.Read more